IMMUNOCORE HLDGS PLC's ticker is IMCR and the CUSIP is 45258D105. A total of 46 filers reported holding IMMUNOCORE HLDGS PLC in Q2 2021. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $130,855 | -9.9% | 2,521,284 | +4.0% | 0.02% | -5.0% |
| Q2 2023 | $145,309 | +112.4% | 2,423,420 | +75.2% | 0.02% | +100.0% |
| Q1 2023 | $68,398 | -10.2% | 1,383,440 | +3.7% | 0.01% | -16.7% |
| Q4 2022 | $76,127 | -99.9% | 1,333,916 | +14.6% | 0.01% | +33.3% |
| Q3 2022 | $54,618,000 | +366.3% | 1,163,561 | +270.7% | 0.01% | +800.0% |
| Q2 2022 | $11,712,000 | +14.1% | 313,899 | -8.6% | 0.00% | 0.0% |
| Q1 2022 | $10,264,000 | -21.1% | 343,279 | -9.6% | 0.00% | 0.0% |
| Q4 2021 | $13,007,000 | -3.1% | 379,891 | +4.9% | 0.00% | 0.0% |
| Q3 2021 | $13,420,000 | -6.4% | 362,026 | -1.4% | 0.00% | 0.0% |
| Q2 2021 | $14,343,000 | -13.1% | 367,304 | -5.3% | 0.00% | -50.0% |
| Q1 2021 | $16,513,000 | – | 387,912 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bill & Melinda Gates Foundation | 576,923 | $21,400,000 | 6.26% |
| Rock Springs Capital Management LP | 2,445,155 | $90,642,000 | 1.91% |
| Avidity Partners Management LP | 1,095,600 | $40,614,000 | 0.90% |
| Bain Capital Public Equity Management II, LLC | 638,205 | $23,658,000 | 0.83% |
| RTW INVESTMENTS, LP | 1,245,532 | $46,172,000 | 0.70% |
| Baker Brothers Advisors | 2,520,730 | $93,443,000 | 0.41% |
| Samsara BioCapital, LLC | 64,000 | $2,372,000 | 0.37% |
| Pier Capital, LLC | 78,514 | $2,911,000 | 0.30% |
| Rhenman & Partners Asset Management AB | 90,000 | $3,336,000 | 0.23% |
| Perceptive Advisors | 400,000 | $14,828,000 | 0.22% |